Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced an oversubscribed $76 million Series B financing co-led ...

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...

Bangladesh experienced major changes to its legal framework through ordinances in 2025. In total, the President promulgated ...

Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...

Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing ExpertiseSAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking ...

Take the circumstances into account: With 4:22 left in the third quarter, Triton Central’s Eli Sego was chasing Will Hegwood ...

A class-action lawsuit filed in Alameda County seeks to block California's Jan. 5 cancellation of nearly 20,000 commercial driver's licenses. The plaintiffs argue the DMV is punishing immigrant ...

Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing Expertise SAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking Therapeutics ...

Our reporters published investigations this year on the Trump administration, health care, education and more. These are the ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Detailed price information for Pharmala Biotech Holdings Inc. (MDMA-CN) from The Globe and Mail including charting and trades.

While DD newsreaders Shammi Narang and Rini Simon Khanna set the standard in Delhi Metro, voice artists in other cities are ...